Geode Capital Management’s Rein Therapeutics RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $344K | Sell |
|
|||||
|
2025
Q1 | $436K | Buy |
|
|||||
|
2024
Q4 | $555K | Buy |
|
|||||
|
2024
Q3 | $814K | Buy |
|
|||||
|
2024
Q2 | $472K | Buy |
|
|||||
|
2024
Q1 | $453K | Buy |
|
|||||
|
2023
Q4 | $174K | Buy |
|
|||||
|
2023
Q3 | $85.3K | Buy |
|
|||||
|
2023
Q2 | $98.5K | Buy |
|
|||||
|
2023
Q1 | $68.5K | Buy |
|
|||||
|
2022
Q4 | $105K | Buy |
|
|||||
|
2022
Q3 | $183K | Buy |
|
|||||
|
2022
Q2 | $226K | Buy |
|
|||||
|
2022
Q1 | $444K | Buy |
|
|||||
|
2021
Q4 | $485K | Buy |
|
|||||
|
2021
Q3 | $839K | Buy |
|
|||||
|
2021
Q2 | $958K | Buy |
|
|||||
|
2021
Q1 | $817K | Buy |
|
|||||
|
2020
Q4 | $238K | Buy |
|
|||||
|
2020
Q3 | $190K | Buy |
|
|||||
|
2020
Q2 | $167K | Buy |
|
|||||
|
2020
Q1 | $36K | Buy |
|
|||||
|
2019
Q4 | $52K | Buy |
|
|||||
|
2019
Q3 | $36K | Hold |
|
|||||
|
2019
Q2 | $39K | Buy |
|
|||||
|
2019
Q1 | $93K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $145K | Buy |
|
|||||
|
2017
Q4 | $161K | Sell |
|
|||||
|
2017
Q3 | $233K | Buy |
|